These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10571625)

  • 1. Guidelines on the management of prostate cancer. A document for local expert groups in the United Kingdom preparing prostate management policy documents.
    ;
    BJU Int; 1999 Dec; 84(9):987-1014. PubMed ID: 10571625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic intraepithelial neoplasia].
    Molinié V
    Ann Pathol; 2001 Jun; 21(3):245-54. PubMed ID: 11468562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostate specific antigen (PSA): impact of a seric marker on the diagnosis and therapeutic management of cancers of the prostate].
    Chauvet B; Jacob T; Davin JL; Berger C; Vincent P; Reboul F
    Bull Cancer Radiother; 1996; 83(4):334-44. PubMed ID: 9081335
    [No Abstract]   [Full Text] [Related]  

  • 4. Early prostate cancer diagnosis and therapy.
    Glodé LM
    Adv Intern Med; 2000; 45():41-64. PubMed ID: 10635045
    [No Abstract]   [Full Text] [Related]  

  • 5. A rational approach to prostate cancer.
    Kirk D
    Practitioner; 2000 Sep; 244(1614):750, 754-6, 758 passim. PubMed ID: 11048371
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conceptual and technical issues in pathologic diagnosis of prostate cancer].
    Jiang ZM; Zhang HZ; Zheng L
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):433-5. PubMed ID: 19781187
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract.
    Häggman MJ; Adolfsson J; Khoury S; Montie JE; Norlén J
    Scand J Urol Nephrol Suppl; 2000; (205):44-9. PubMed ID: 11144903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer in older men.
    Calabrese DA
    Urol Nurs; 2004 Aug; 24(4):258-64, 268; quiz 269. PubMed ID: 15446376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
    Kantoff PW; Talcott JA
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment strategy for prostate cancer].
    Kakehi Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():170-6. PubMed ID: 12599566
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostatic intraepithelial neoplasia: significance and management.
    Lipski BA; Garcia RL; Brawer MK
    Semin Urol Oncol; 1996 Aug; 14(3):149-55. PubMed ID: 8865477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).
    Villers A; Pommier P; Bataillard A; Fervers B; Bachaud JM; Berger N; Bertrand AF; Bouvier R; Brune D; Daver A; Fontaine E; Haillot O; Lagrange JL; Molinie V; Muratet JP; Pabot du Chatelard P; Peneau M; Prapotnich D; Ravery V; Richaud P; Rossi D; Soulie M; ;
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S50-8. PubMed ID: 12915903
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility of using guidelines to choose treatment for prostate cancer.
    Mohan R; Beydoun H; Davis J; Lance R; Schellhammer P
    Can J Urol; 2010 Feb; 17(1):4975-84. PubMed ID: 20156376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostatic cancer].
    Soulié M; Barré C; Beuzeboc P; Chautard D; Cornud F; Eschwege P; Fontaine E; Molinié V; Moreau JL; Péneau M; Ravery V; Rébillard X; Richaud P; Ruffion A; Salomon L; Staerman F; Villers A;
    Prog Urol; 2004 Nov; 14(4 Suppl 1):913, 915-55. PubMed ID: 15779654
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues.
    Häggman MJ; Macoska JA; Wojno KJ; Oesterling JE
    J Urol; 1997 Jul; 158(1):12-22. PubMed ID: 9186314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance and management of prostatic intraepithelial neoplasia].
    Chen Z
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):883-5. PubMed ID: 15638012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Summary of 'General Rule for Clinical and Pathological Studies on Prostate Cancer (the 3rd Edition)'].
    Maeda O; Usami M
    Nihon Rinsho; 2005 Feb; 63(2):201-6. PubMed ID: 15714966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caring for a patient with metastatic prostate cancer.
    Held-Warmkessel J
    Nursing; 2008 Jun; 38(6):52-6. PubMed ID: 18497662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant hormone therapy in prostatic cancer: after treatment with curative intent. The viewpoint of the urologist].
    Martorana G
    Recenti Prog Med; 2002 Mar; 93(3):179-82. PubMed ID: 11942170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.